Engineered dendritic cells capture tumor EVs, enhancing antigen presentation and T cell activation to boost cancer immunotherapy in preclinical models.
Around the same time, Mack Fulwyler, an engineer working at Los Alamos National Laboratory, needed to separate particles, so he drew on existing techniques to create droplets to separate cells from a ...
EPFL researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback